VCP Scanner
Stock Screener
Filter stocks with fundamental & technical criteria
Market Themes
Curated industry baskets & thematic leaders
Earnings Hub
Calendar, EPS surprise stats & earnings transcripts
Market News
Real-time market intelligence & AI overviews
Insider Buying
SEC Form 4 corporate insider purchases
LearnAll lessons
Candlestick Patterns44 candles, each on two real charts
Pattern GuidesThe playbooks' setups on real breakouts
GlossaryInvesting terms in plain English
MinerviniVCP SetupsTrend Template
O'NeilCup with HandleFlat BaseDouble BottomCANSLIM Leaders
QullamaggieHigh Tight FlagsFlag BreakoutsEpisodic PivotsMomentum Leaders
KellWedge PopEMA Crossback
LivermorePivotal Points
PatternsFalling Wedge & ChannelBase Breakouts
View All Playbooks...
BreakoutsScanner
FAANG & Tech
AAPL vs MSFTNVDA vs AMDGOOGL vs META
Cloud & Cyber
CRM vs NOWCRWD vs PANWSNOW vs DDOG
Consumer & Auto
TSLA vs FAMZN vs WMTNFLX vs DIS
Finance & Crypto
JPM vs BACV vs MACOIN vs MSTR
Index & ETFs
SPY vs QQQVTI vs VOOSPY vs IWM
Compare Any Stocks...
DCF ValuationCalculate intrinsic value of US stocks
Market ValuationBuffett indicator, CAPE & macro gauges
Total ReturnSee dividends + price return history
DCA CalculatorSimulate recurring buys & compounding
VisualizeInteractive multi-year financial charts
Watchlist
BreakoutsScanner
WatchlistPricing
Ctrl K
Pricing
XERS
← Back to Screener
VCP ScannerFree US Stock Screener & Financial Analysis

Find stocks. Analyze deeply. Research with clarity.

Data updated daily

Product

  • Screener
  • Scanner
  • Themes
  • Valuation
  • Total Return
  • DCA Calculator
  • Pricing
  • News
  • Earnings

Resources

  • Market Valuation
  • Compare
  • Insider Activity
  • Methodology
  • How It Works
  • Glossary
  • Learn

Get Ideas

Get weekly market insights — free

© 2026 VCP Scanner
AboutPrivacyTermsRefund Policy
Not financial advice. Do your own research.
ScreenerBreakoutsScannerWatchlist
XERSXeris Biopharma Holdings, Inc.
$16.99$2.9B
Overview & Tools
OverviewChart Terminal ↗Visualize
Valuation & Forecasts
Valuation ModelsEstimatesDCF Model
Price & Analyst Data
Analyst TargetsPrice History
Financial Statements
Income StatementBalance SheetCash FlowRatios & Margins
Performance
P/E HistoryRevenue HistoryEarnings HistoryDividend HistoryTotal Return
Discovery & Screens
Live BreakoutsStock ScreenerOwnership
HomeStocksXERSQuarterly Balance Sheet

Xeris Biopharma Holdings, Inc. (XERS) Quarterly Balance Sheet

120+ quarters historyFree accessUpdated daily

Xeris Biopharma Holdings, Inc. (XERS) quarterly balance sheet — complete assets, liabilities & equity history

Income StatementBalance SheetCash FlowRatios

XERS Balance Sheet

Quarterly statement

XERS Balance Sheet

Xeris Biopharma Holdings, Inc. (XERS) balance sheet — 10-year assets, liabilities & shareholders' equity history

AnnualQuarterly
MetricQ3'26Q2'26Q1'26Q4'25Q3'25Q2'25Q1'25Q4'24Q3'24Q2'24Q1'24Q4'23Q3'23Q2'23Q1'23Q4'22Q3'22Q2'22Q1'22Q4'21
Total Current Assets289.26M274.76M251.68M240.31M224.02M185.58M163.49M167.66M162.8M170.34M173.28M156.26M158.05M155.74M165.51M186.82M148.92M161.21M177.55M142.6M
Cash & Short-Term Investments131.08M121.75M111.75M111.04M91.6M59.28M58.44M71.62M69.4M77.57M87.35M72.45M65.97M80.67M95.1M121.97M93.43M111.55M132.15M102.43M
Cash Only131.08M121.75M111.75M111.04M91.6M59.28M58.44M71.62M59.23M57.6M62.69M67.45M46.14M46.17M50.98M121.97M84.11M95.34M103.77M67.27M
Short-Term Investments0000000010.17M19.96M24.66M5M19.83M34.5M44.12M09.32M16.21M28.38M35.16M
Accounts Receivable68.6M58.1M56.3M51.05M53.75M53.05M46.33M40.41M41.14M42.44M37.41M39.2M45.97M30.23M30.86M30.83M27.52M25.76M23.38M17.46M
Days Sales Outstanding54.3656.5258.1156.1866.0563.2164.9362.4270.8475.5985.7888.2572.5373.1383.6380.9882.4488.3583.2665.84
Inventory76.92M80.93M74.23M68.67M67.46M67.28M52.69M48.17M45.12M42.98M40.88M38.84M38.14M36.54M29.04M24.73M20.12M17.89M16.87M18.12M
Days Inventory Outstanding584.22564.26484.1328.23563.68373.65520.04452.79298.13363.37607.45344.43418.89394.94454.94327.99332.39328.8251304.46
Other Current Assets12.66M09.4M9.55M11.21M5.96M6.03M7.45M7.14M7.36M7.64M5.78M7.97M8.31M10.51M9.29M06.01M5.15M0
Total Non-Current Assets133.95M137.15M140.33M143.21M146.17M149.11M151.96M155.4M158.31M161.39M163.34M166.34M169.73M173.04M155.85M157.7M154.1M157.41M160.07M161.76M
Property, Plant & Equipment26.22M26.61M26.98M27.06M27.21M27.69M27.79M28.21M28.37M28.7M28.81M29.18M29.59M30.18M10.36M9.51M5.75M6.17M6.29M6.63M
Fixed Asset Turnover4.06x3.44x3.08x3.16x2.71x2.58x2.15x2.12x1.90x1.67x1.40x1.51x1.62x1.87x3.34x4.34x4.99x4.06x3.42x3.26x
Goodwill22.86M22.86M22.86M22.86M22.86M22.86M22.86M22.86M22.86M22.86M22.86M22.86M22.86M22.86M22.86M22.86M22.86M22.86M22.86M22.86M
Intangible Assets79.95M82.66M85.37M88.08M90.79M93.5M96.21M98.92M101.63M104.34M107.05M109.76M112.47M115.19M117.9M120.61M123.32M126.03M128.74M131.45M
Long-Term Investments004.02M0004.12M4.12M04.22M0000000000
Other Non-Current Assets4.93M5.03M1.1M5.22M5.32M5.06M975K1.28M5.44M1.27M4.61M4.54M4.81M4.81M4.73M4.73M2.17M2.35M2.18M829K
Total Assets423.22M411.9M392.01M383.53M370.19M334.69M315.45M323.06M321.1M331.73M336.62M322.6M327.78M328.78M321.36M344.52M303.02M318.62M337.62M304.36M
Asset Turnover0.26x0.23x0.21x0.23x0.21x0.22x0.19x0.19x0.17x0.14x0.12x0.14x0.15x0.12x0.10x0.10x0.10x0.08x0.07x0.10x
Asset Growth %14.32%23.07%24.27%18.72%15.29%0.89%-6.29%0.14%-2.04%0.9%4.75%-6.36%8.17%3.19%-4.82%13.2%130.85%110.31%101.4%91.24%
Total Current Liabilities134.48M189.57M118.59M109.57M116.2M95.17M95.07M100.44M91.01M75.49M73.08M95.19M87.04M79.68M81.42M73.62M68.56M64.55M66.49M79.04M
Accounts Payable8.04M9.34M11.47M3.08M6.53M9.46M6.35M2.29M7.45M5.8M7.09M11.56M12.08M11.62M11.98M4.61M3.92M6.63M11.09M8.92M
Days Payables Outstanding64.3175.6549.2623.1566.8949.2544.5647.2844.8455.87142.18105.79132.93142.16140.3562.3192.24167.64143.58124.33
Short-Term Debt063.78M6.27M6.23M6.19M011.96M15.1M15.06M000000000341K0
Deferred Revenue (Current)00000000000000000000
Other Current Liabilities4.02M4.98M100.86M100.27M103.48M36.46M32.38M39.75M34.83M51.56M26.78M51.43M43.69M40.64M39.73M27.23M18.41M17.63M19.38M25.63M
Current Ratio2.15x1.45x2.12x2.19x1.93x1.95x1.72x1.67x1.79x2.26x2.37x1.64x1.82x1.95x2.03x2.54x2.17x2.50x2.67x1.80x
Quick Ratio1.58x1.02x1.50x1.57x1.35x1.24x1.17x1.19x1.29x1.69x1.81x1.23x1.38x1.50x1.68x2.20x1.88x2.22x2.42x1.57x
Cash Conversion Cycle574.27545.12492.95361.25562.84387.61540.42467.93324.13383.1551.04326.9358.49325.91398.22346.66322.6249.51190.68245.98
Total Non-Current Liabilities239.96M232.07M260.41M260.26M254.85M258.82M255.51M252.23M258.41M275.53M272.71M234.19M236.88M235.46M209.89M225.71M179.42M180.13M174.68M130.09M
Long-Term Debt189.71M188.81M31.06M31.53M31.99M218.63M217.81M217.01M216.23M230.48M229.67M190.93M190.42M188.18M187.62M187.07M138.51M138.07M137.64M88.07M
Capital Lease Obligations30M30.54M00032.44M32.87M33.26M33.64M34.02M34.4M34.76M35.15M34.87M9.35M9.4M0000
Deferred Tax Liabilities0000000003.32M2.58M2.27M2.5M2.84M3.52M3.52M3.86M4.2M4.53M4.94M
Other Non-Current Liabilities20.24M12.72M229.35M228.73M222.86M7.75M4.83M1.97M8.55M7.71M6.06M6.23M8.8M9.56M9.4M25.72M37.06M37.87M32.5M37.08M
Total Liabilities374.44M421.64M379M369.84M371.05M353.99M350.58M352.68M349.43M351.02M345.79M329.38M323.92M315.14M291.31M299.33M247.98M244.67M241.17M209.13M
Total Debt226.07M289.44M37.33M37.76M38.19M257.22M268.75M271.45M270.96M269.8M268.69M229.19M227.94M224.99M198.42M198.06M138.51M138.07M137.98M88.07M
Net Debt94.98M167.69M-74.42M-73.28M-53.41M197.94M210.31M199.83M211.73M212.2M206M161.74M181.8M178.82M147.43M76.09M54.4M42.73M34.21M20.8M
Debt / Equity4.63x-2.87x2.76x--------58.98x16.49x6.60x4.38x2.52x1.87x1.43x0.92x
Debt / EBITDA11.33x34.53x3.36x1.91x3.85x33.64x5070.77x56.41x------------
Net Debt / EBITDA4.76x20.00x-6.69x-3.70x-5.38x25.89x3968.13x41.53x------------
Interest Coverage2.75x-3.48x1.32x1.55x1.09x0.74x-0.26x0.34x-1.45x-0.79x-1.66x-0.94x-0.83x-2.14x-1.71x-2.04x-4.56x-6.69x-8.69x-27.28x
Total Equity48.78M-9.73M13.01M13.69M-861K-19.3M-35.13M-29.61M-28.32M-19.29M-9.18M-6.78M3.87M13.64M30.05M45.19M55.04M73.94M96.45M95.23M
Equity Growth %5765.97%49.58%137.04%146.22%96.96%-0.09%-282.74%-336.67%-832.81%-241.38%-130.54%-115.01%-92.98%-81.55%-68.85%-52.55%2336.49%271.8%117.3%182.07%
Book Value per Share0.26-0.060.070.08-0.00-0.12-0.23-0.20-0.19-0.13-0.07-0.050.030.100.220.330.400.550.710.78
Total Shareholders' Equity48.78M-9.73M13.01M13.69M-861K-19.3M-35.13M-29.61M-28.32M-19.29M-9.18M-6.78M3.87M13.64M30.05M45.19M55.04M73.94M96.45M95.23M
Common Stock19K18K18K17K17K16K16K15K15K15K15K14K14K14K14K14K14K14K14K13K
Retained Earnings-688.88M-700.17M-669.07M-671.31M-682.39M-683.01M-681.08M-671.86M-666.75M-651.01M-636M-617.02M-603.63M-591.45M-571.6M-554.77M-541.84M-520.01M-493.82M-460.11M
Treasury Stock00000000000000000000
Accumulated OCI-11K-10K-24K-25K-25K-24K-25K-25K-16K-31K-36K-25K-50K-78K-29K-23K-37K-52K-66K-31K
Minority Interest00000000000000000000